SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-23-014947
Filing Date
2023-08-15
Accepted
2023-08-15 06:30:22
Documents
45
Period of Report
2023-08-15

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20230815x6k.htm 6-K 20468
2 EX-99.01 tmb-20230815xex99d01.htm EX-99.01 68645
3 GRAPHIC tmb-20230815xex99d01g001.jpg GRAPHIC 137658
4 GRAPHIC tmb-20230815xex99d01g002.jpg GRAPHIC 372025
5 GRAPHIC tmb-20230815xex99d01g003.jpg GRAPHIC 214237
6 GRAPHIC tmb-20230815xex99d01g004.jpg GRAPHIC 184227
7 GRAPHIC tmb-20230815xex99d01g005.jpg GRAPHIC 166281
8 GRAPHIC tmb-20230815xex99d01g006.jpg GRAPHIC 97193
9 GRAPHIC tmb-20230815xex99d01g007.jpg GRAPHIC 169807
10 GRAPHIC tmb-20230815xex99d01g008.jpg GRAPHIC 95363
11 GRAPHIC tmb-20230815xex99d01g009.jpg GRAPHIC 100454
12 GRAPHIC tmb-20230815xex99d01g010.jpg GRAPHIC 119956
13 GRAPHIC tmb-20230815xex99d01g011.jpg GRAPHIC 202735
14 GRAPHIC tmb-20230815xex99d01g012.jpg GRAPHIC 190720
15 GRAPHIC tmb-20230815xex99d01g013.jpg GRAPHIC 176022
16 GRAPHIC tmb-20230815xex99d01g014.jpg GRAPHIC 163972
17 GRAPHIC tmb-20230815xex99d01g015.jpg GRAPHIC 165459
18 GRAPHIC tmb-20230815xex99d01g016.jpg GRAPHIC 101229
19 GRAPHIC tmb-20230815xex99d01g017.jpg GRAPHIC 139609
20 GRAPHIC tmb-20230815xex99d01g018.jpg GRAPHIC 126593
21 GRAPHIC tmb-20230815xex99d01g019.jpg GRAPHIC 88957
22 GRAPHIC tmb-20230815xex99d01g020.jpg GRAPHIC 192465
23 GRAPHIC tmb-20230815xex99d01g021.jpg GRAPHIC 93949
24 GRAPHIC tmb-20230815xex99d01g022.jpg GRAPHIC 121952
25 GRAPHIC tmb-20230815xex99d01g023.jpg GRAPHIC 128979
26 GRAPHIC tmb-20230815xex99d01g024.jpg GRAPHIC 156897
27 GRAPHIC tmb-20230815xex99d01g025.jpg GRAPHIC 107431
28 GRAPHIC tmb-20230815xex99d01g026.jpg GRAPHIC 151201
29 GRAPHIC tmb-20230815xex99d01g027.jpg GRAPHIC 120799
30 GRAPHIC tmb-20230815xex99d01g028.jpg GRAPHIC 149340
31 GRAPHIC tmb-20230815xex99d01g029.jpg GRAPHIC 123805
32 GRAPHIC tmb-20230815xex99d01g030.jpg GRAPHIC 102326
33 GRAPHIC tmb-20230815xex99d01g031.jpg GRAPHIC 163956
34 GRAPHIC tmb-20230815xex99d01g032.jpg GRAPHIC 158950
35 GRAPHIC tmb-20230815xex99d01g033.jpg GRAPHIC 141367
36 GRAPHIC tmb-20230815xex99d01g034.jpg GRAPHIC 104042
37 GRAPHIC tmb-20230815xex99d01g035.jpg GRAPHIC 100620
38 GRAPHIC tmb-20230815xex99d01g036.jpg GRAPHIC 144692
39 GRAPHIC tmb-20230815xex99d01g037.jpg GRAPHIC 89930
40 GRAPHIC tmb-20230815xex99d01g038.jpg GRAPHIC 121987
41 GRAPHIC tmb-20230815xex99d01g039.jpg GRAPHIC 97755
42 GRAPHIC tmb-20230815xex99d01g040.jpg GRAPHIC 127107
43 GRAPHIC tmb-20230815xex99d01g041.jpg GRAPHIC 88187
44 GRAPHIC tmb-20230815xex99d01g042.jpg GRAPHIC 184295
45 GRAPHIC tmb-20230815xex99d01g043.jpg GRAPHIC 137658
  Complete submission text file 0001558370-23-014947.txt   8527238
Mailing Address YALELAAN 62 UTRECHT P7 3584 CM
Business Address YALELAAN 62 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Filer) CIK: 0001840748 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40241 | Film No.: 231173164
SIC: 2834 Pharmaceutical Preparations